Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SCHWAB CHARLES CORP (SCHW)

  • Business News
  • June 12, 2026, 12:45 UTC
  • 5
  • 1 comments

Schwab Reports Monthly Activity Highlights

Market reaction Comment Full text

POP CULTURE GROUP CO., LTD (CPOP)

  • Business News
  • June 12, 2026, 12:45 UTC
  • 4
  • 1 comments

Pop Culture Group Co., Ltd Announces Pricing of $8 Million Registered Direct Offering

Market reaction Comment Full text

Cel-Sci Corporation (CVM)

  • Business News
  • June 12, 2026, 12:44 UTC
  • 7
  • 1 comments

Notification from CEL SCI CORP

Market reaction Comment Full text

NEWTEKONE, INC. (NEWT)

  • Business News
  • June 12, 2026, 12:44 UTC
  • 5
  • 1 comments

NewtekOne, Inc. Declares Dividends on Common Stock and Series B Preferred Shares

Market reaction Comment Full text

TOTALENERGIES SE (TTE)

  • Business News
  • June 12, 2026, 12:44 UTC
  • 4
  • 1 comments

Director/PDMR Shareholding

Market reaction Comment Full text

CAESARS ENTERTAINMENT, INC. (CZR)

  • Business News
  • June 12, 2026, 12:40 UTC
  • 6
  • 1 comments

A New Jewel on the Las Vegas Strip: Lisa Vanderpump Celebrates Grand Opening of The Vanderpump Hotel

Market reaction Comment Full text

CSOP ASSET MANAGEMENT PTE. LTD. (LCS)

  • Business News
  • June 12, 2026, 12:33 UTC
  • 2
  • 0 comments

General Announcement: Net Asset Value per unit

Market reaction Comment Full text

CSOP ASSET MANAGEMENT PTE. LTD. (LCS)

  • Business News
  • June 12, 2026, 12:33 UTC
  • 2
  • 0 comments

General Announcement: Net Asset Value per unit

Market reaction Comment Full text

CSOP INVESTMENTS III VCC (SUN)

  • Business News
  • June 12, 2026, 12:32 UTC
  • 2
  • 0 comments

General Announcement: Net Asset Value per unit

Market reaction Comment Full text

PEPSICO INC (PEP)

  • Business News
  • June 12, 2026, 12:32 UTC
  • 5
  • 1 comments

Clinical trial NCT07400614 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-08-30 → 2026-07-15 3. primary completion date: 2026-08-30 → 2026-07-15

Market reaction Comment Full text
  • Previous
  • 2243
  • 2244
  • 2245
  • 2246
  • 2247
  • Next

Search

News categories

  • Technical Exchange News(14023)
  • Event(6229)
  • SEC News(356696)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(216121)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin